Table 2. Motivators for getting a COVID-19 vaccine, by essential worker group and vaccination intent, United States, March–June 2021*.
| Reason | All groups, n = 5,308 |
Healthcare personnel,
n = 1,308 |
Frontline workers,
n = 2,300 |
Other workers, n = 1,700 |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total† | R, n = 714 | RL, n = 1,059 | Total | R, n = 121 | RL, n = 197 | Total | R, n = 316 | RL, n = 437 | Total | R, n = 277 | RL, n = 425 | ||||
| Prevent COVID-19 spread to family and friends |
51.4 (49.6–53.2) |
26.0 (22.0–30.3)
|
4.7 (3.1–6.9) |
|
58.0 (54.4–61.4) |
30.5 (20.3–42.3)
|
7.7 (2.5–17.2)† |
|
50.5 (47.7–53.3) |
30.7 (24.4–37.5)
|
4.1 (2.2–6.8) |
|
47.6 (44.7–50.5) |
19.1 (13.7–25.4)
|
3.7 (2.0–6.3) |
| More information on vaccine effectiveness |
44.4 (42.7–46.2) |
31.1 (26.7–35.7)
|
14.1 (11.6–16.9) |
|
46.0 (42.6–49.4) |
26.4 (17.6–36.8)
|
13.7 (8.5–20.5) |
|
44.9 (42.3–47.5) |
29.1 (23.5–35.2)
|
17.1 (13.1–21.7) |
|
42.6 (39.7–45.6) |
35.0 (27.7–42.9)
|
11.0 (7.4–15.6) |
| Reduce COVID-19 spread in community |
41.9 (40.2–43.6) |
19.4 (15.9–23.2)
|
2.9 (1.7–4.7) |
|
45.8 (42.3–49.4) |
14.5 (8.3–23.0)
|
3.0 (1.1–6.5)† |
|
42.5 (39.8–45.2) |
20.9 (16.0–26.6)
|
3.2 (1.0–7.3)† |
|
37.9 (35.0–40.9) |
19.4 (13.5–26.4)
|
2.6 (1.1–5.2) |
| Ability to resume social activities |
36.7 (35.0–38.3) |
15.5 (12.3–19.2)
|
2.2 (1.3–3.3) |
|
38.5 (35.1–42.0) |
9.0 (4.5–15.7)
|
1.2 (0.2–3.8) |
|
37.7 (35.3–40.2) |
14.3 (9.9–19.6)
|
3.6 (1.9–6.1) |
|
33.8 (31.1–36.5) |
19.3 (13.4–26.3)
|
1.2 (0.4–2.8) |
| More severe COVID-19 cases |
33.4 (31.8–35.0) |
13.7 (10.8–17.0)
|
4.8 (3.4–6.6) |
|
36.2 (32.9–39.5) |
14.4 (7.8–23.6)
|
2.2 (0.7–5.4) |
|
33.6 (31.2–36.1) |
13.1 (9.1–18.1)
|
6.2 (3.5–10.0) |
|
30.9 (28.3–33.6) |
14.0 (9.3–19.9)
|
4.7 (2.7–7.5) |
| Ability to travel |
31.3 (29.8–32.8) |
16.9 (13.8–20.5)
|
6.9 (5.1–9.1) |
|
32.5 (29.2–35.9) |
15.0 (8.1–24.5) |
7.4 (3.2–14.2)† |
|
32.4 (30.1–34.7) |
16.4 (12.1–21.6)
|
6.4 (4.1–9.4) |
|
28.8 (26.2–31.4) |
18.3 (12.7–24.9)
|
7.1 (4.3–10.8) |
| Someone I know became seriously ill or died from COVID-19 |
22.1 (20.8–23.5) |
9.4 (6.8–12.6) |
6.4 (4.6–8.5) |
|
24.1 (21.4–27.0) |
11.7 (5.6–21.0)† |
2.7 (0.8–6.6)† |
|
21.7 (19.7–23.9) |
11.5 (6.9–17.8) |
8.0 (5.2–11.6) |
|
21.0 (18.7–23.4) |
6.1 (3.6–9.6) |
6.6 (3.9–10.4) |
| Recommend by a healthcare provider |
17.2 (16.0–18.5) |
14.1 (10.9–17.9)
|
3.6 (2.2–5.5) |
|
19.9 (17.4–22.6) |
13.5 (6.3–24.2)† |
3.9 (0.8–11.0)† |
|
16.8 (14.9–18.7) |
15.5 (10.8–21.2)
|
4.2 (2.2–7.4) |
|
15.7 (13.7–17.9) |
12.9 (7.7–19.8)
|
2.8 (1.2–5.5) |
| Workplace or school requirement |
14.9 (13.8–16.1) |
29.1 (25.0–33.5)
|
14.2 (11.8–17.0) |
|
19.9 (17.2–22.9) |
39.5 (28.6–51.2)
|
10.8 (6.5–16.7) |
|
13.7 (12.0–15.4) |
27.2 (21.6–33.5)
|
17.1 (13.0–21.9) |
|
12.8 (10.8–15.0) |
27.4 (20.9–34.7)
|
13.0 (9.4–17.4) |
| Vaccine safety information available |
14.8 (13.4–16.3) |
39.8 (35.4–44.5)
|
20.8 (17.9–24.1) |
|
11.7 (9.3–14.6) |
46.6 (35.6–57.9)
|
21.2 (14.7–28.9) |
|
14.2 (12.2–16.4) |
36.8 (30.5–43.3)
|
21.7 (17.1–26.8) |
|
18.0 (15.2–21.1) |
40.7 (33.3–48.6)
|
19.7 (15.1–25.1) |
| Enables children back to school |
14.8 (13.6–16.0) |
8.1 (5.9–10.9)
|
1.5 (0.7–2.8) |
|
16.5 (13.9–19.3) |
12.6 (5.6–23.3)† |
2.0 (0.6–5.1) |
|
16.0 (14.2–17.8) |
8.5 (5.4–12.4)
|
2.2 (0.6–5.2) |
|
11.8 (10.0–13.8) |
6.1 (3.3–10.1)
|
0.4 (0.0–1.6) |
| Enables me to get back to work or school |
12.4 (11.2–13.7) |
4.8 (3.2–7.0)
|
1.4 (0.7–2.7) |
|
14.3 (11.7–17.3) |
2.2 (0.4–6.7)† |
1.7 (0.4–4.6) |
|
14.9 (13.0–16.8) |
6.4 (3.7–10.3)
|
2.0 (0.5–5.1) |
|
7.5 (6.1–9.2) |
4.1 (1.9–7.5)† |
0.7 (0.1–2.1) |
| Recommended by a family member or friend |
11.9 (10.8–13.0) |
5.4 (3.7–7.7)
|
1.3 (0.6–2.4) |
|
11.2 (9.0–13.7) |
7.6 (2.3–17.8)† |
2.2 (0.6–5.3) |
|
13.0 (11.4–14.8) |
5.9 (3.4–9.4)
|
1.7 (0.5–4.4) |
|
10.8 (9.1–12.6) |
4.2 (2.1–7.2)
|
0.3 (0.0–1.3) |
| See community members getting vaccinated |
10.3 (9.1–11.5) |
5.2 (3.4–7.5)
|
2.6 (1.3–4.6) |
|
10.5 (8.2–13.2) |
10.2 (3.7–21.3)† |
2.1 (0.6–5.2) |
|
11.7 (9.8–13.8) |
5.3 (3.0–8.6) |
4.5 (1.7–9.4)† |
|
8.2 (6.7–9.9) |
3.2 (1.4–6.0)
|
0.7 (0.1–2.2) |
| Large increase in COVID-19 cases in my area |
3.1 (2.5–3.9) |
10.1 (7.7–13.0)
|
3.2 (2.0–4.9) |
|
2.3 (1.2–4.1) |
13.5 (6.4–24.1)† |
2.1 (0.5–5.3) |
|
3.2 (2.2–4.4) |
7.8 (5.1–11.4) |
5.1 (2.6–8.8) |
|
3.7 (2.5–5.4) |
11.4 (7.2–17.1)
|
1.8 (0.7–3.7) |
| None of the above | 19.9 (18.3–21.5) | 14.1 (11.1–17.6) | 55.9 (52.1–59.6) | 15.6 (12.3–19.4) | 10.7 (5.8–17.7) | 54.1 (44.3–63.6) | 17.7 (15.4–20.1) | 11.9 (8.1–16.7) | 52.7 (46.6–58.7) | 26.2 (23.3–29.2) | 17.8 (12.1–24.9) | 60.5 (54.5–66.3) | |||
*Values are reported as % respondents (95% CI). n values indicate unweighted sample size/denominator. Bold text indicates statistical significance (p<0.05) between reachable and reluctant groups; reluctant group is the referent. R respondents were defined as adults who probably would or were unsure about getting a COVID-19 vaccine. RL respondents were defined as adults who probably or definitely would not get a COVID-19 vaccine. COVID-19, coronavirus disease; R, reachable; RL, reluctant.
†Estimates do not meet the National Center for Health Statistics standards of reliability (https://www.cdc.gov/nchs/data/series/sr_02/sr02_175.pdf).